Back

Spatio-temporal mapping of immune cell dynamics during human sequential lymph node metastasis

Zhao, Q.; Lu, Y.; Shi, Z.; Zhang, H.; Li, C. S.; Zhao, R.; Ling, Y.; Gao, Y.; Zhang, Z.; Sun, X.; Qian, Y.; Wang, X.; Wang, C.; Cong, B.; Ni, X.; Liu, Y.; Zhao, M.; Wang, Y.; Mahata, B.; Qiu, P.

2026-03-19 immunology
10.64898/2026.03.17.712495 bioRxiv
Show abstract

Regional lymph node (LN) metastasis critically influences distant metastatic progression, anti-tumour immunity, and patient prognosis. While tumour-induced immune modulation in tumour-draining LNs (TDLNs) has been extensively studied using murine models, the systematic reconstruction of the immune system from primary tumours through TDLNs and subsequent lymph nodes in human cancer progression remains understudied. Here, we utilised integrated multi-omics approaches, including imaging mass cytometry, single-cell RNA sequencing, Visium and Xenium spatial transcriptomics, and multi-colour immunofluorescence to systematically characterise immune cell dynamics across 147 paired primary tumours, sentinel TDLNs (S-TDLNs), and secondary axillary LNs (ALNs) obtained from 50 treatment-naive triple-negative breast cancer patients with different progression statuses. Our comprehensive profiling revealed critical immune alterations, such as decreased type-2 conventional dendritic cells (cDC2), naive T cells, and B cells, along with an increase in immunosuppressive macrophages. Developing a novel single-cell transformer model, we identified substantial alterations in various immune cell populations, notably MARCO+ macrophages, which strongly correlated with breast cancer patient survival outcomes. Spatial analysis combined with our newly integrated cell-cell interaction platform revealed diminished immune cell communication and impaired priming interactions among dendritic cells, B cells, and T cells within metastatic lymph nodes and primary tumour sites. In an independent neoadjuvant immunotherapy cohort of 36 TNBC patients with 52 lymph node samples, we found preservation of CD1c cDC2 in lymph nodes predicted pathological complete response and longer event-free survival, highlighting cDC2 as a potential biomarker and therapeutic target. Collectively, this systematic mapping of immune landscape alterations during human sequential LN metastasis provides essential insights for understanding cancer metastasis mechanisms and paves the way for innovative immunotherapeutic strategies.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 10%
14.4%
2
Cell Reports
1338 papers in training set
Top 5%
7.2%
3
Advanced Science
249 papers in training set
Top 3%
4.9%
4
Cell
370 papers in training set
Top 4%
4.9%
5
eLife
5422 papers in training set
Top 20%
4.3%
6
Cell Reports Medicine
140 papers in training set
Top 1%
4.0%
7
Immunity
58 papers in training set
Top 1%
4.0%
8
Cell Systems
167 papers in training set
Top 4%
3.6%
9
Nature Immunology
71 papers in training set
Top 0.6%
3.6%
50% of probability mass above
10
Genome Medicine
154 papers in training set
Top 3%
3.1%
11
iScience
1063 papers in training set
Top 10%
2.1%
12
Cancer Immunology Research
34 papers in training set
Top 0.2%
2.1%
13
Frontiers in Immunology
586 papers in training set
Top 3%
2.1%
14
EMBO Molecular Medicine
85 papers in training set
Top 1%
1.9%
15
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.9%
16
Nature Cancer
35 papers in training set
Top 0.7%
1.7%
17
Nucleic Acids Research
1128 papers in training set
Top 11%
1.7%
18
Science Advances
1098 papers in training set
Top 17%
1.7%
19
Cancer Cell
38 papers in training set
Top 1%
1.5%
20
Communications Biology
886 papers in training set
Top 12%
1.3%
21
Science Immunology
81 papers in training set
Top 1%
1.3%
22
PLOS Biology
408 papers in training set
Top 14%
1.2%
23
eBioMedicine
130 papers in training set
Top 2%
1.1%
24
Nature Biotechnology
147 papers in training set
Top 7%
0.8%
25
Nature
575 papers in training set
Top 15%
0.8%
26
Breast Cancer Research
32 papers in training set
Top 0.5%
0.7%
27
Cell Genomics
162 papers in training set
Top 6%
0.7%
28
Theranostics
33 papers in training set
Top 2%
0.7%
29
Scientific Reports
3102 papers in training set
Top 76%
0.7%
30
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 47%
0.6%